Litcius/Paper detail

Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study

Ohad Atia, Zivia Shavit-Brunschwig, Raffi Lev‐Tzion, Ronen Stein, Efrat Broide, Darja Urlep, Jeffrey S. Hyams, Batia Weiss, M Aloi, Amit Assa, Konstantinos Gerasimidis, Ben Nichols, Richard K. Russell, Dan Turner

2025˜The œLancet. Gastroenterology & hepatology11 citationsDOIOpen Access PDF

Topics & Concepts

VedolizumabMedicineInflammatory bowel diseaseProspective cohort studyPediatricsCohortCohort studyInternal medicineDiseaseIntensive care medicineInflammatory Bowel DiseaseCeliac Disease Research and ManagementPregnancy and Medication Impact
Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study | Litcius